CTNNB1 and endometrial cancer: Since several other proteins, including S100P, are regulatory components of a novel ubiquitinylation complex involved in β-catenin degradation, further studies are in need with specific regard to trigger for β-catenin nuclear localization in endometrial cancer in the absence of CTNNB1 mutations [32].